Skip to main content
Diagnostics logoLink to Diagnostics
. 2021 Mar 28;11(4):601. doi: 10.3390/diagnostics11040601

Proteomic Expression Profile in Human Temporomandibular Joint Dysfunction

Andrea Duarte Doetzer 1,*, Roberto Hirochi Herai 1, Marília Afonso Rabelo Buzalaf 2, Paula Cristina Trevilatto 1
Editor: Gustavo Baldassarre
PMCID: PMC8066727  PMID: 33800589

Abstract

Temporomandibular joint dysfunction (TMD) is a multifactorial condition that impairs human’s health and quality of life. Its etiology is still a challenge due to its complex development and the great number of different conditions it comprises. One of the most common forms of TMD is anterior disc displacement without reduction (DDWoR) and other TMDs with distinct origins are condylar hyperplasia (CH) and mandibular dislocation (MD). Thus, the aim of this study is to identify the protein expression profile of synovial fluid and the temporomandibular joint disc of patients diagnosed with DDWoR, CH and MD. Synovial fluid and a fraction of the temporomandibular joint disc were collected from nine patients diagnosed with DDWoR (n = 3), CH (n = 4) and MD (n = 2). Samples were subjected to label-free nLC-MS/MS for proteomic data extraction, and then bioinformatics analysis were conducted for protein identification and functional annotation. The three TMD conditions showed different protein expression profiles, and novel proteins were identified in both synovial fluid and disc sample. TMD is a complex condition and the identification of the proteins expressed in the three different types of TMD may contribute to a better comprehension of how each pathology develops and evolutes, benefitting the patient with a focus–target treatment.

Keywords: temporomandibular joint, protein expression, temporomandibular joint dysfunction

1. Introduction

Temporomandibular dysfunction (TMD) is a disorder of the masticatory system and it is characterized by pain, loss of function of one or both articulations, and impairment of the masticatory system. TMD impacts not only jaw function, but the life quality of affected patients, increasing their treatment costs and work absence [1]. According to the National Institute of Health [2], TMD management in the USA costs approximately 4 billion dollars per year. A diagnostic protocol developed for research named Research Diagnostic Criteria for TMD (RDC/TMD), classifies TMD as myalgia, arthralgia, condylar pathologies, disc displacement, osteoarthrosis, osteoarthritis, degenerative joint disease and subluxation [3]. TMD has a multifactorial etiology, the most common being trauma, psychological alterations, hormone, inflammatory diseases, parafunction, and genetics [1,4]. TMD usually requires a panorex, and depending on the TMD type, magnetic resonance imaging, scintigraphy and tomography, besides a thorough clinical evaluation [5,6].

Depending on the TMD type, it can be classified as condylar hyperplasia (CH), disc displacement without reduction (DDWoR) and mandibular dislocation (MD). DDWoR is the most common TMD disorder [7], and along with CH, its etiology’s understanding is still unclear. MD is a condition that is probably caused by physical alterations [8], and since it is less likely to have hormone contribution, it is a good TMD condition to compare the results with the other pathologies. DDWoR is caused by an abnormal positional association between the disc and the condyle, where the disc is permanently anteriorly displaced in relation to the condyle, causing limited range of mouth opening, pain and may lead to temporomandibular joint (TMJ) degeneration [9]. Disc displacement corresponds to 41% of TMD intra-articular disorders [7], and it is considered a multifactorial disease, with overlapping conditions contributing to its modulation including stress, parafunction, behavioral pattern, emotional status, and genetic background [3]. Among its different types of treatment, clinical handling is firstly employed (splint therapy, medication, physiotherapy) and when unsuccessful, surgery is indicated [6,10]. MD is an involuntary forward movement of the condyle beyond the articular eminence, mostly associated with trauma or excessive mouth opening, impairing its essential functions (speaking, chewing), and it accounts for 3% of all documented dislocations [11]. It usually needs mechanical manipulation to return to its normal position, and recurrent dislocations require surgical treatment [8]. Between these TMD types, CH is the rarest pathology that manifests a head condyle overgrowth, causing facial asymmetry, deformity, malocclusion and sometimes pain and dysfunction [12]. It is a self-limiting condition, more prevalent in female teenagers, but it usually requires surgical treatment to limit facial asymmetry progression and condyle continuous elongation [13]. Studies suggest it has a genetic involvement on its development, but its main etiology is still poorly understood [14].

Despite the etiological differences between CH, DDWoR and MD, current studies have limited understanding of the molecular variations that differentiates these TMD diseases. Condylar hyperplasia, mandibular dislocation and disc displacement have been the aim of many studies, due to their difficulty in targeting the proper treatment to each disease [9]. The employment of specific treatment, which may be improved with the unveiling of its specific etiology factors, will allow us to diminish treatment time and costs.

At the proteomic level, current studies focus only on individual mandibular dysfunctions, without comparing different TMD types to show the proteomic variability that could drive novel biomarkers as targets for disease diagnostic and treatment [15,16]. Proteomic analysis is a gold standard approach to analyze all identifiable proteins in a certain tissue, investigating its abundance, variety of proteoforms, and their stable or transient protein–protein interactions. This approach is especially beneficial in the clinical setting when studying proteins involved in different pathologies [17]. To date, there are very few studies investigating human TMD samples through proteomic output, and these studies analyzed only synovial fluid, focusing on specific target proteins [15,16]. Therefore, analyzing all proteins present in the synovial fluid and disc sample of different types of TMD may potentially lead TMD treatments towards a new reality.

In this research, a high throughput proteomic investigation of the three TMD pathologies CH, DDWoR and MD, was performed. Using state-of-the-art sample extraction procedures, biological samples of synovial fluid and TMJ discs were collected from distinct patients diagnosed with these conditions. The samples were processed, subjected to protein extraction and mass spectrometry proteomic identification. Generated proteomic data were analyzed using bioinformatics methods, and a per-sample protein identification and annotation were performed. The clinical phenotypes were then used to correlate the proteomic profile of each TMD condition.

2. Materials and Methods

2.1. Sample Selection

The sample was composed of 9 disc and synovial fluid specimens from female patients, with a mean age of 31.22 years (18–52). The patients presented different TMJ conditions, with three samples being composed of TMJ displaced disc without reduction (n = 3), two mandibular dislocation (n = 2) and four patients with condylar hyperplasia (n = 4) (Table 1). The specimens were collected from patients treated at the Evangelic University Hospital of Curitiba, Brazil. The study was approved by the Ethical Committee on Research at Pontifical Catholic University of Paraná, Brazil, according to Resolution 196/96 of the National Health Council and approved on 6 May of 2016 under registration number 1.863.521.

Table 1.

Baseline characteristics of the sample, showing age and pathology of each female patient.

Number Age Diagnostic
1 18 Condylar Hyperplasia
2 20 Condylar Hyperplasia
3 38 Mandibular Dislocation
4 38 Mandibular Dislocation
5 36 Condylar Hyperplasia
6 29 Condylar Hyperplasia
7 25 Disc Displacement Without Reduction
8 25 Disc Displacement Without Reduction
9 52 Disc Displacement Without Reduction

Subjects did not present any of the following criteria: use of orthodontic appliances; chronic usage of anti-inflammatory drugs; history of diabetes, hepatitis, HIV infection; immunosuppressive chemotherapy; history of any disease known to compromise immune function; pregnancy or lactation; major jaw trauma; previous TMJ surgery; and previous steroid injection in the TMJ.

Subjects answered a personal medical history questionnaire and signed a consent form after being advised of the nature of the study. All patients were clinically examined by one experienced oral and maxillofacial surgeon. The clinical examination consisted of palpating the TMJ region, analyzing the occurrence of painful or limitation/excessiveness of mouth opening/closing, and the observation of facial asymmetry. Regarding complementary exams, all patients had a panorex and patients with disc displacement were submitted to a magnetic resonance image. The patients who were considered to be affected with disc displacement were treated surgically when they presented painful clinical signs of disc displacement after unsuccessful non-surgical treatment for at least 6 months [18]. Patients presenting pain related only to muscular spasms were not included in this research. Patients with condylar hyperplasia were diagnosed through clinical evaluation, panorex and when presenting a positive condylar growth in scintilography, a high condylectomy was indicated and performed [19]. Patients with recidivist mandibular dislocation (more than four episodes in six months) were treated with eminectomy [8].

2.2. Sample Acquisition

During access to the TMJ to perform the needed surgery [20], a 21-gauge needle was inserted into the upper TMJ space, then 1 mL of saline was injected into the joint space, which was aspirated thereafter by a second adapted syringe. This procedure was repeated five times to obtain a synovial fluid sample as described previously by Alstergren [21]. For each type of surgery performed, TMJ disc recontouring and repositioning was needed [16], therefore, first the displaced disc was freed, repositioned and sutured to the latero-posterior side of the condyle with a Mitek bone-cleat. The suture was then placed between the posterior and intermediate bands, and recontouring the thickened disk with a scalpel was necessary (this posterior debrided cartilage constituted the disc sample). Synovial fluid was spun down at 300× g to remove debris, and stored at −80°C until use or analysis, and the disc samples rinsed in phosphate-buffered saline (PBS), and either snap frozen in liquid nitrogen and stored at −80°C.

2.3. Proteomic Analysis

The microcentrifuge tubes containing the synovial fluid and TMJ discs were removed from the −80 ° C freezer, and after defrosting, the discs were cut into small pieces with the aid of sterile scissors, centrifuged, and the supernatants were collected and pooled according to each pathology group. The preparation of the samples for proteomic analysis was carried out as previously reported [22]. The analysis of the tryptic peptides was performed in the nanoACQUITY UPLC system (Waters, Milliford, CT, USA) coupled to the Xevo Q-TOF G2 mass spectrometer (MS) (Waters, Milliford, CT, USA). For this purpose, the UPLC nanoACQUITY system was equipped with a column of type HSS T3 (Acquity UPLC HSS T3 column 75 mm × 150 mm; 1.8 µm, Waters), previously balanced with 7% of the mobile phase B (100% ACN + 0.1% formic acid). The peptides were separated through a linear gradient of 7%–85% of the mobile phase B over 70 min with a flow of 0.35 µL/min and the column temperature maintained at 45 °C. The MS was operated in positive ion mode, with a 75 min data acquisition time. The obtained data were processed using ProteinLynx GlobalServer (PLGS) version 3.03 (Waters, Milliford, CT, USA). Protein identification was obtained using the ion counting algorithm incorporated into the software. The collected data were searched in the database of the species Homo sapiens downloaded from the catalog of the UniProt [23] in September of 2020. The identified proteins for the groups DDWoR, MD, and CH of synovial fluid and TMJ disc were classified and attributed by biological function, origin, and molecular interaction with the program Genemania [24]. The overlapping proteins between the groups were clustered by using an automatic Venn diagram generator.

3. Results

In this qualitative study, our aim was to explore, for the first time, a comparative analysis of the proteomic profile of three distinct TMD diseases. Although a statistical analysis was not performed, we were able to identify and describe the function of the proteins, including overlapping proteins between the investigated samples (DDWoR, MD and CH, and between both synovial fluid and disc samples).

In the synovial fluid samples, a total of 225 proteins (351 counting the repeated proteins in all groups) were successfully identified: 190 in the group DDWoR, 154 in the group MD and seven in the group CH. We also compared these three groups to identify shared or condition-specific proteins. We found 114 shared proteins between groups DDWoR and MD, and six proteins were shared by all groups (Table 2).

Table 2.

Gene code and name of the proteins expressed in synovial fluid of all groups (disc displacement without reduction (DDWoR), mandibular dislocation (MD), condylar hyperplasia (CH) and between the groups DDWoR and MD, DDWoR and CH, MD and CH and DDWoR, MD and CH.

Protein Expressed in Each Group of TMJ Synovial Fluid Sample (n = 225)
DDWoR (n = 70) MD (n = 34) CH (n = 1) DDWoR and MD (n = 114) DDWoR and CH (n = 0) MD and CH (n = 0) DDWoR, MD and CH (n = 6)
Code Name Code Name Code Name Code Name X X Code Name
A2M Alpha-2-Macroglobulin ACTR3B Actin Related Protein 3B ADH1 Alcohol Dehydrogenase Subunit Alpha ABI3BP ABI Family Member 3 Binding Protein ENO1 Enolase 1
ANXA5 Annexin A5 ACTR3C Actin Related Protein 3C ACTA1 Actin Alpha 1, Skeletal Muscle ENO2 Enolase 2
APCS Amyloid P Component AKNA AT-Hook Transcription Factor ACTA2 Actin Alpha 2, Smooth Muscle ENO3 Enolase 3
APOH Apolipoprotein H ALDH1L1 Aldehyde Dehydrogenase 1 Family Member L1 ACTB Actin Beta MYH16 Myosin Heavy Chain 16 Pseudogene
ARHGAP21 Rho GTPase Activating Protein 21 C4A Complement C4A (Rodgers Blood Group) ACTBL2 Actin Beta Like 2 RPL7L1 Ribosomal Protein L7 Like 1
CFH Complement Factor H C4B_2 Complement Component 4B ACTC1 Actin Alpha Cardiac Muscle 1 SHLD3 Shieldin Complex Subunit 3
CHD8 Chromodomain Helicase DNA Binding Protein 8 C7orf57 Complement C7 ACTG1 Actin Gamma 1
CILP2 Cartilage Intermediate Layer Protein CAGE1 Cancer Antigen 1 ACTG2 Actin Gamma 2, Smooth Muscle
CNOT6L CCR4-NOT Transcription Complex Subunit 6 Like CPSF2 Cleavage And Polyadenylation Specific Factor 2 ALB Albumin
DAGLA Diacylglycerol Lipase Alpha DCAF4L2 DDB1 And CUL4 Associated Factor 4 Like 2 ANXA1 Annexin A1
DPYSL2 Dihydropyrimidinase Like 2 DHRS11 Dehydrogenase/Reductase 11 ANXA2 Annexin A2
DPYSL3 Dihydropyrimidinase Like 3 DMD Dystrophin ANXA2P2 Annexin A2 Pseudogene 2
DYM Dymeclin FLNA Filamin A APOA1 Apolipoprotein A1
DYNC1H1 Dynein Cytoplasmic 1 Heavy Chain HPR Haptoglobin-Related Protein ASPN Asporin
ENPP3 Ectonucleotide Pyrophosphatase/Phosphodiesterase 3 HPX Hemopexin ATP5F1B ATP Synthase F1 Subunit Beta
FGFR2 Fibroblast Growth Factor Receptor 2 IFT122 Intraflagellar Transport 122 BGN Biglycan
GPSM2 G Protein Signaling Modulator 2 LMO7 LIM Domain 7 C3 Complement C3
GPX3 Glutathione Peroxidase 3 MYO6 Myosin VI CILP Cartilage Intermediate Layer Protein
GSTP1 Glutathione S-Transferase Pi 1 PDIA3 Protein Disulfide Isomerase Family A Member 3 CLU Clusterin
H2BC1 H2B Clustered Histone 1 PPFIA1 PTPRF Interacting Protein Alpha 1 COL12A1 Collagen Type XII Alpha 1 Chain
H2BE1 H2B.E Variant Histone 1 PPFIA2 PTPRF Interacting Protein Alpha 2 COL14A1 Collagen Type XIV Alpha 1 Chain
HSPA1A Heat Shock Protein Family A (Hsp70) Member 1A PRDX1 Peroxiredoxin 1 COL1A1 Collagen Type I Alpha 1 Chain
HSPA1B Heat Shock Protein Family A (Hsp70) Member 1B PRDX2 Peroxiredoxin 2 COL6A1 Collagen Type VI Alpha 1 Chain
HSPA1L Heat Shock Protein Family A (Hsp70) Member 1 Like RGMB Repulsive Guidance Molecule BMP Co-Receptor B COL6A2 Collagen Type VI Alpha 2 Chain
HSPA2 Heat Shock Protein Family A (Hsp70) Member 2 SACM1L SAC1 Like Phosphatidylinositide Phosphatase COL6A3 Collagen Type VI Alpha 3 Chain
HSPA8 Heat Shock Protein Family A (Hsp70) Member 8 SERPINA9 Serpin Family A Member 9 COMP Thrombospondin-5
IGLC1 Immunoglobulin Lambda Constant 1 SERPINH1 Serpin Family H Member 1 DCN Decorin
IGLC2 Immunoglobulin Lambda Constant SLC4A1 Solute Carrier Family 4 Member 1 DES Desmin
IGLC3 Immunoglobulin Lambda Constant 3 SMPD3 Sphingomyelin Phosphodiesterase 3 DPT Dermatopontin
Immunoglobulin Lambda Constant 6 Teneurin Transmembrane Protein 4 Fibrillin 1
IGLC6 Immunoglobulin Lambda Constant 7 TENM4 Transmembrane O-Mannosyltransferase Targeting Cadherins 3 FBN1 Fibrinogen Alpha Chain
IGLC7 Immunoglobulin Lambda Like Polypeptide 1 TMTC3 Testis Specific 10 FGA Fibrinogen Beta Chain
IGLL1 Immunoglobulin Lambda Like Polypeptide 5 TSGA10 Transthyretin FGB Fibrinogen Gamma Chain
IGLL5 Interferon Regulatory Factor 7 TTR Ubiquitin Specific Peptidase 10 FGG Fibromodulin
IRF7 Kalirin RhoGEF Kinase USP10 Actin Related Protein 3B FMOD Fibronectin 1
KALRN Kelch Repeat And BTB Domain Containing 11 FN1 Glyceraldehyde-3-Phosphate Dehydrogenase
KBTBD11 Keratocan GAPDH Gelsolin
KERA Keratin 18 GSN H2B Clustered Histone 11
KRT18 Keratin 7 H2BC11 H2B Clustered Histone 12
KRT7 Keratin 8 H2BC12 H2B Clustered Histone 13
KRT8 Keratin 84 H2BC13 H2B Clustered Histone 14
KRT84 Putative Uncharacterized Protein H2BC14 H2B Clustered Histone 15
LOC400499 Leucine Rich Repeat Containing 9 H2BC15 H2B Clustered Histone 17
LRRC9 Mitogen-Activated Protein Kinase Kinase Kinase 7 H2BC17 H2B Clustered Histone 18
MAP3K7 Microfibril Associated Protein 5 H2BC18 H2B Clustered Histone 21
MFAP5 Myosin Light Chain 6B H2BC21 H2B Clustered Histone 3
MYL6B NCK Associated Protein 5 H2BC3 H2B Clustered Histone 5
NCKAP5 Nik Related Kinase H2BC5 H2B Clustered Histone 9
NRK Pericentriolar Material 1 H2BC9 H2B.S Histone 1
PCM1 Procollagen C-Endopeptidase Enhancer H2BS1 H2B.U Histone 1
PCOLCE RAD54 Like H2BU1 Hemoglobin Subunit Alpha 1
RAD54L Retinol Dehydrogenase 5 HBA1 Hemoglobin Subunit Alpha 2
RDH5 Ret Proto-Oncogene HBA2 Hemoglobin Subunit Beta
RET Regulatory Factor X1 HBB Hemoglobin Subunit Delta
RFX1 RPTOR Independent Companion Of MTOR Complex 2 HBD Hemoglobin Subunit Epsilon 1
RICTOR RIMS Binding Protein 3 HBE1 Hemoglobin Subunit Gamma 1
RIMBP3 RUN And FYVE Domain Containing 2 HBG1 Hemoglobin Subunit Gamma 2
RUFY2 Serpin Family C Member 1 HBG2 Haptoglobin
SERPINC1 Serpin Family F Member 1 HP Heat Shock Protein Family B (Small) Member 1
SERPINF1 SEC14 And Spectrin Domain Containing 1 HSPB1 Immunoglobulin Heavy Constant Alpha 1
SESTD1 Small Nuclear Ribonucleoprotein U5 Subunit 200 IGHA1 Immunoglobulin Heavy Constant Alpha 2 (A2m Marker)
SNRNP200 SVOP Like IGHA2 Immunoglobulin Heavy Constant Gamma 1 (G1m Marker
SVOPL Transcription Elongation Factor, Mitochondrial IGHG1 Immunoglobulin Heavy Constant Gamma 2
TEFM Thrombospondin 3 IGHG2 Immunoglobulin Heavy Constant Gamma 3
THBS3 Tenascin C IGHG3 Immunoglobulin Heavy Constant Gamma 4
TNC Trio Rho Guanine Nucleotide Exchange Factor IGHG4 Immunoglobulin Kappa Constant
TRIO Tubulin Beta 1 Class VI IGKC Internexin Neuronal Intermediate Filament Protein Alpha
TUBB1 Ubiquitin Specific Peptidase 42 INA Galectin 1
USP42 WW Domain Binding Protein 1 Like LGALS1 Lamin
WBP1L Zinc Finger ZZ-Type And EF-Hand Domain Containing 1 LMNA Lumican
ZZEF1 H2B Clustered Histone 1 LUM Microfibril Associated Protein 4
MFAP4 Myosin Light Chain 6
MYL6 Myocilin
MYOC Neurofilament Heavy
NEFH Neurofilament Light
NEFL Neurofilament Medium
NEFM Osteoglycin
OGN Pellino E3 Ubiquitin Protein Ligase Family Member 3
PELI3 Pyruvate Kinase M1/2
PKM POTE Ankyrin Domain Family Member E
POTEE POTE Ankyrin Domain Family Member F
POTEF POTE Ankyrin Domain Family Member I
POTEI POTE Ankyrin Domain Family Member J
POTEJ POTE Ankyrin Domain Family Member K, Pseudogene
POTEKP Peptidylprolyl Isomerase A
PPIA Proline And Arginine Rich End Leucine Rich Repeat Protein
PRELP Peripherin
PRPH S100 Calcium Binding Protein A10
S100A10 Serpin Family A Member 1
SERPINA1 Superoxide Dismutase 3
SOD3 Transferrin
TF Transforming Growth Factor Beta Induced
TGFBI Thrombospondin 4
THBS4 Tenascin XA
TNXA Tenascin XB
TNXB Tubulin Alpha 1a
TUBA1A Tubulin Alpha 1b
TUBA1B Tubulin Alpha 1c
TUBA1C Tubulin Alpha 3c
TUBA3C Tubulin Alpha 3d
TUBA3D Tubulin Alpha 3e
TUBA3E Tubulin Alpha 4a
TUBA4A Tubulin Alpha 8
TUBA8 Tubulin Beta Class I
TUBB Tubulin Beta 2A Class IIa
TUBB2A Tubulin Beta 2B Class IIb
TUBB2B Tubulin Beta 3 Class III
TUBB3 Tubulin Beta 4A Class IVa
TUBB4A Tubulin Beta 4B Class IVb
TUBB4B Tubulin Beta 6 Class V
TUBB6 Tubulin Beta 8 Class VIII
TUBB8 Tubulin Beta 8B
TUBB8B Versican
VCAN VIM
VIM ABI Family Member 3 Binding Protein

In the disc sample, 379 proteins were identified (697 counting the repeated proteins in all groups), with 235 proteins in group DDWoR, 196 in group MD and 266 in group CH. These three groups were also compared to identify shared or condition-specific proteins. There were nine shared proteins between groups DDWoR and MD, 28 shared proteins between groups DDWoR and CH, 17 shared proteins between groups MD and CH, and 132 shared proteins by all groups (Table 3).

Table 3.

Gene code and name of the proteins expressed in temporomandibular joint (TMJ) discs of all groups (DDWoR, MD, CH) and between the groups DDWoR and MD, DDWoR and CH, MD and CH and DDWoR, MD and CH.

Protein Expressed in Each Group of TMJ Disc Sample (n = 379)
DDWoR
(n= 66)
MD (n = 38) CH (n = 89) DDWoR and MD (n = 9) DDWoR and CH (n = 28) MD and CH (n = 17) DDWoR, MD and CH
(n = 132)
Code Name Code Name Code Name Code Name Code Name Code Name Code Name
ABCC9 ATP Binding Cassette Subfamily C Member 9 AFTPH Aftiphilin ACTN1 Actinin Alpha 1 ATP7B ATPase Copper Transporting Beta ACAN Aggrecan ATP5F1B ATP Synthase F1 Subunit Beta A2M Alpha-2-Macroglobulin
ACSS3 Acyl-CoA Synthetase Short Chain Family Member 3 AKAP13 A-kinase anchor protein 13 ACTN4 Actinin Alpha 4 AXIN2 Axin 2 APOH Apolipoprotein H GFAP Glial Fibrillary Acidic Protein ABI3BP ABI Family Member 3 Binding Protein
AGO4 Argonaute RISC Component 4 ALDH3A2 Aldehyde dehydrogenase family 3 member A2 ACTR3 Actin Related Protein 3 C4A Complement C4A BRD3 Bromodomain Containing 3 KRT3 Keratin 3 ACTA1 Actin Alpha 1, Skeletal Muscle
AMBP Alpha-1-Microglobulin/Bikunin Precursor ANKRD44 Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B ADAM10 ADAM Metallopeptidase Domain 10 C4B Complement C4B CLTC Clathrin Heavy Chain KRT5 Keratin 5 ACTA2 Actin Alpha 2, Smooth Muscle
ANKRD17 Ankyrin Repeat Domain 17 ANKRD52 Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C ADSL Adenylosuccinate Lyase C4B_2 Complement Component 4B COL1A1 Collagen Type I Alpha 1 Chain KRT6A Keratin 6A ACTB Actin Beta
ARHGAP35 Rho GTPase Activating Protein 35 ARMH3 Armadillo-like helical domain-containing protein 3 ALDOA Aldolase, Fructose-Bisphosphate A KERA Keratocan COL4A6 Collagen Type IV Alpha 6 Chain KRT6B Keratin 6B ACTBL2 Actin Beta Like 2
ARHGEF10 Rho Guanine Nucleotide Exchange Factor 10 CCDC88A Girdin ALDOC Aldolase, Fructose-Bisphosphate C KIAA0556 Katanin Interacting Protein DNAH8 Defensin Alpha 1 KRT6C Keratin 6C ACTC1 Actin Alpha Cardiac Muscle 1
ATAD2B ATPase Family AAA Domain Containing 2B CLUH Clustered mitochondria protein homolog ANKMY1 Ankyrin Repeat And MYND Domain Containing 1 MAP4 Microtubule Associated Protein 4 EEF1A1 Dynein Axonemal Heavy Chain 8 KRT75 Keratin 75 ACTG1 Actin Gamma 1
BCAS2 BCAS2 Pre-MRNA Processing Factor COL4A1 Collagen alpha-1(IV) chain ANXA5 Annexin A5 SEMA4F Semaphorin 4F EEF1A1P5 Eukaryotic Translation Elongation Factor 1 Alpha 1 KRT76 Keratin 76 ACTG2 Actin Gamma 2
CARNS1 Carnosine Synthase 1 DOCK10 Dedicator of cytokinesis protein 10 ANXA6 Annexin A6 EEF1A2 Eukaryotic Translation Elongation Factor 1 Alpha 1 Pseudogene 5 KRT78 Keratin 78 ALB Albumin
CCDC187 Coiled-Coil Domain Containing 187 DTHD1 Death domain-containing protein 1 ASXL1 ASXL Transcriptional Regulator 1 HMCN2 Eukaryotic Translation Elongation Factor 1 Alpha 2 KRT79 Keratin 79 ANXA1 Annexin A1
CDCP1 CUB Domain Containing Protein 1 ERAS GTPase ERas ATP2C1 ATPase Secretory Pathway Ca2+ Transporting 1 HSPA2 Hemicentin 2 KRT81 Keratin 81 ANXA2 Annexin A2
CDH3 Cadherin 3 ERBIN Erbin BLOC1S1 Biogenesis Of Lysosomal Organelles Complex 1 Subunit 1 HSPA8 Heat Shock Protein Family A (Hsp70) Member 2 KRT83 Keratin 83 ANXA2P2 Annexin A2 Pseudogene 2
CHD7 Chromodomain Helicase DNA Binding Protein 7 FLNA Filamin-A BRCA2 BRCA2 DNA Repair Associated HYDIN Heat Shock Protein Family A (Hsp70) Member 8 KRT85 Keratin 85 APCS Amyloid P Component
CHD8 Chromodomain Helicase DNA Binding Protein 8 GOT1L1 Putative aspartate aminotransferase, cytoplasmic 2 CABP5 Calcium Binding Protein 5 IGLC1 HYDIN Axonemal Central Pair Apparatus Protein KRT86 Keratin 86 APOA1 Apolipoprotein A1
CHD9 Chromodomain Helicase DNA Binding Protein 9 HHLA1 HERV-H LTR-associating protein 1 CACNA2D3 Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 3 IGLC2 Immunoglobulin Lambda Constant 1 PKM Pyruvate Kinase M1/2 ASPN Asporin
CSTF2T Cleavage Stimulation Factor Subunit 2 Tau Variant IGHV3OR16–9 Immunoglobulin heavy variable 3/OR16–9 (non-functional) CCDC18 Coiled-Coil Domain Containing 18 IGLC3 Immunoglobulin Lambda Constant 2 TTBK2 Tau Tubulin Kinase 2 BGN Biglycan
ECH1 Enoyl-CoA Hydratase 1 KDF1 Keratinocyte differentiation factor 1 CDC20 Cell Division Cycle 20 IGLC6 Immunoglobulin Lambda Constant 3 C3 Complement C3
ELAVL3 ELAV Like RNA Binding Protein 3 L1CAM Neural cell adhesion molecule L1 CENPF Centromere Protein F IGLC7 Immunoglobulin Lambda Constant 6 CILP Cartilage Intermediate Layer Protein
EML4 EMAP Like 4 MARK1 Serine/threonine-protein kinase MARK1 CFAP20DC CFAP20 Domain Containing IGLL1 Immunoglobulin Lambda Constant 7 CILP2 Cartilage Intermediate Layer Protein 2
FARP2 FERM, ARH/RhoGEF And Pleckstrin Domain Protein 2 NEIL3 Endonuclease 8-like 3 CNTN1 Contactin 1 IGLL5 Immunoglobulin Lambda Like Polypeptide 1 CLU Clusterin
FBN1 Fibrillin 1 NOL8 Nucleolar protein 8 COQ8B Coenzyme Q8B LOC441081 Immunoglobulin Lambda Like Polypeptide 5 COL12A1 Collagen Type XII Alpha 1 Chain
GALK2 Galactokinase 2 NUFIP1 Nuclear fragile X mental retardation-interacting protein 1 CTNNA3 Catenin Alpha 3 MIS18BP1 POM121 Membrane Glycoprotein (Rat) Pseudogene COL14A1 Collagen Type XIV Alpha 1 Chain
GPR162 G Protein-Coupled Receptor 162 NUMA1 Nuclear mitotic apparatus protein 1 DPYSL2 Dihydropyrimidinase Like 2 MYO15B MIS18 Binding Protein 1 COL6A1 Collagen Type VI Alpha 1 Chain
GPRASP1 G Protein-Coupled Receptor Associated Sorting Protein 1 PARP10 Protein mono-ADP-ribosyltransferase PARP10 EHD2 EH Domain Containing 2 POSTN Myosin XVB COL6A2 Collagen Type VI Alpha 2 Chain
IKBKE Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Epsilon PCDHA4 Protocadherin alpha-4 EYS Eyes Shut Homolog SERPINA9 Periostin COL6A3 Collagen Type VI Alpha 3 Chain
INS Insulin POLD1 DNA polymerase delta catalytic subunit F13A1 Coagulation Factor XIII A Chain VTN Serpin Family A Member 9 COMP Cartilage Oligomeric Matrix Protein
IRF2BPL Interferon Regulatory Factor 2 Binding Protein Like POM121L2 POM121-like protein 2 GOLGA4 Golgin A4 DCN Decorin
ITGA6 Integrin Subunit Alpha 6 PPFIA1 Liprin-alpha-1 GSTP1 Glutathione S-Transferase Pi 1 DES Desmin
KRT26 Keratin 26 PPFIA2 Liprin-alpha-2 GVINP1 GTPase, Very Large Interferon Inducible Pseudogene 1 DMD Dystrophin
LEMD2 LEM Domain Nuclear Envelope Protein 2 PRR14L Protein PRR14L H3-2 H3.2 Histone (Putative) DPT Dermatopontin
MAP3K21 Mitogen-Activated Protein Kinase Kinase Kinase 21 PTPN7 Tyrosine-protein phosphatase non-receptor type 7 H3-3A H3.3 Histone A ENO1 Enolase 1
MDGA1 MAM Domain Containing Glycosylphosphatidylinositol Anchor 1 RASSF10 Ras association domain-containing protein 10 H3-3B H3.3 Histone B ENO2 Enolase 2
MMP10 Matrix Metallopeptidase 10 RPS6KA6 Ribosomal protein S6 kinase alpha-6 H3-4 H3.4 Histone ENO3 Enolase 3
MMP27 Matrix Metallopeptidase 27 TRIO TRIO and F-actin-binding protein H3-5 H3.5 Histone FBLN1 Fibulin 1
MMP3 Matrix Metallopeptidase 3 TSC1 Hamartin HEATR6 HEAT Repeat Containing 6 FGA Fibrinogen Alpha Chain
MOS MOS Proto-Oncogene, Serine/Threonine Kinas UPK3A Uroplakin-3a HPX Hemopexin FGB Fibrinogen Beta Chain
MYL6 Myosin Light Chain 6 UROD Uroporphyrinogen decarboxylase HSP90B1 Heat Shock Protein 90 Beta Family Member 1 FGG Fibrinogen Gamma Chain
MYO7B Myosin VIIB HSPA1A Heat Shock Protein Family A (Hsp70) Member 1A FLNB Filamin B
NT5E 5’-Nucleotidase Ecto HSPA1B Heat Shock Protein Family A (Hsp70) Member 1B FMOD Fibromodulin
OLFML1 Olfactomedin Like 1 HSPA1L Heat Shock Protein Family A (Hsp70) Member 1 Like FN1 Fibronectin 1
PGM5 Phosphoglucomutase 5 HSPA5 Heat Shock Protein Family A (Hsp70) Member 5 GAPDH Glyceraldehyde-3-Phosphate Dehydrogenase
PHKA2 Phosphorylase Kinase Regulatory Subunit Alpha 2 IGFN1 Immunoglobulin Like And Fibronectin Type III Domain Containing 1 GPX3 Glutathione Peroxidase 3
PLA2G7 Phospholipase A2 Group VII INF2 Inverted Formin 2 GSN Angiotensin I Converting Enzyme 2
POR Cytochrome P450 Oxidoreductase L3MBTL4 L3MBTL Histone Methyl-Lysine Binding Protein 4 H2BC1 H2B Clustered Histone 1
RANBP17 RAN Binding Protein 17 LMNB1 Lamin B1 H2BC11 H2B Clustered Histone 11
RGS22 Regulator Of G Protein Signaling 22 LMNB2 Lamin B2 H2BC12 H2B Clustered Histone 12
RIF1 Replication Timing Regulatory Factor 1 MFAP5 Microfibril Associated Protein 5 H2BC13 H2B Clustered Histone 13
RTN4 Reticulon 4 MRPL50 Mitochondrial Ribosomal Protein L50 H2BC14 H2B Clustered Histone 14
SARS2 Seryl-TRNA Synthetase 2, Mitochondrial MS4A6A Membrane Spanning 4-Domains A6A H2BC15 H2B Clustered Histone 15
SEPHS2 Selenophosphate Synthetase 2 MUC4 Mucin 4, Cell Surface Associated H2BC17 H2B Clustered Histone 17
SLFN13 Schlafen Family Member 13 MYH14 Myosin Heavy Chain 14 H2BC18 H2B Clustered Histone 18
SLK STE20 Like Kinase MYL6B Myosin Light Chain 6B H2BC21 H2B Clustered Histone 21
SPATA20 Spermatogenesis Associated 20 NEK10 NIMA Related Kinase 10 H2BC3 H2B Clustered Histone 3
SPATA5 Spermatogenesis Associated 5 PAK3 P21 (RAC1) Activated Kinase 3 H2BC5 H2B Clustered Histone 5
SPTA1 Spectrin Alpha, Erythrocytic 1 PAPOLA Poly(A) Polymerase Alpha H2BC9 H2B Clustered Histone 9
SQLE Squalene Epoxidase PAPOLG Poly(A) Polymerase Gamma H2BS1 H2B.S Histone 1
ST20-AS1 ST20 Antisense RNA 1 PDIA3 Protein Disulfide Isomerase Family A Member 3 H2BU1 H2B.U Histone 1
STIL STIL Centriolar Assembly Protein PDLIM4 PDZ And LIM Domain 4 HBA1 Hemoglobin Subunit Alpha 1
TACC2 Transforming Acidic Coiled-Coil Containing Protein 2 RALBP1 RalA Binding Protein 1 HBA2 Hemoglobin Subunit Alpha 2
TAP1 Transporter 1, ATP Binding Cassette Subfamily B Member RNF213 Ring Finger Protein 213 HBB Hemoglobin Subunit Beta
THADA THADA Armadillo Repeat Containing SBF2 SET Binding Factor 2 HBD Hemoglobin Subunit Delta
THBS3 Thrombospondin 3 SERPINF1 Serpin Family F Member 1 HBE1 Hemoglobin Subunit Epsilon 1
UQCRC1 Ubiquinol-Cytochrome C Reductase Core Protein 1 SERPINH1 Serpin Family H Member 1 HBG1 Hemoglobin Subunit Gamma 1
VWA3A Von Willebrand Factor A Domain Containing 3A SLC4A5 Solute Carrier Family 4 Member 5 HBG2 Hemoglobin Subunit Gamma 2
ZNF333 Zinc Finger Protein 333 SLIT2 Slit Guidance Ligand 2 HBZ Hemoglobin Subunit Zeta
SMPD3 Sphingomyelin Phosphodiesterase 3 HP Haptoglobin
TAPT1 Transmembrane Anterior Posterior Transformation 1 HPR Haptoglobin-Related Protein
TBX22 T-Box Transcription Factor 22 HSPB1 Heat Shock Protein Family B (Small) Member 1
TDRD1 Tudor Domain Containing 1 IGHA1 Immunoglobulin Heavy Constant Alpha 1
TENM4 Teneurin Transmembrane Protein 4 IGHA2 Immunoglobulin Heavy Constant Alpha 2 (A2m Marker)
THBS1 Thrombospondin 1 IGHG1 Immunoglobulin Heavy Constant Gamma 1 (G1m Marker)
TJP2 Tight Junction Protein 2 IGHG2 Immunoglobulin Heavy Constant Gamma 2 (G2m Marker)
TTR Transthyretin IGHG3 Immunoglobulin Heavy Constant Gamma 3 (G3m Marker)
UBP1 Upstream Binding Protein 1 IGHG4 Immunoglobulin Heavy Constant Gamma 4 (G4m Marker)
WHRN Whirlin IGKC Immunoglobulin Kappa Constant
ZNF155 Zinc Finger Protein 155 INA Internexin Neuronal Intermediate Filament Protein Alpha
ZNF221 Zinc Finger Protein 221 KRT7 Keratin 7
KRT8 Keratin 8
KRT84 Keratin 84
LGALS1 Galectin 1
LMNA Lamin A/C
LUM Lumican
MFAP4 Microfibril Associated Protein 4
MFGE8 Milk Fat Globule EGF And Factor V/VIII Domain Containing
MYH16 Myosin Heavy Chain 16 Pseudogene
MYOC Myocilin
NEFH Neurofilament Heavy
NEFL Neurofilament Light
NEFM Neurofilament Medium
OGN Osteoglycin
POTEE POTE Ankyrin Domain Family Member E
POTEF POTE Ankyrin Domain Family Member F
POTEI POTE Ankyrin Domain Family Member I
POTEJ POTE Ankyrin Domain Family Member J
POTEKP POTE Ankyrin Domain Family Member K, Pseudogene
PPIA Peptidylprolyl Isomerase A
PRDX1 Peroxiredoxin 1
PRDX2 Peroxiredoxin 2
PRELP Proline And Arginine Rich End Leucine Rich Repeat Protein
PRPH Peripherin
RPL7L1 Ribosomal Protein L7 Like 1
S100A10 S100 Calcium Binding Protein A10
SALL3 Spalt Like Transcription Factor 3
SERPINA1 Serpin Family A Member
SHLD3 Shieldin Complex Subunit 3
SLC4A1 Solute Carrier Family 4 Member 1
SOD3 Superoxide Dismutase 3
TF Transferrin
TGFBI Transforming Growth Factor Beta Induced
THBS4 Thrombospondin 4
TNC Tenascin C
TNXA Tenascin XA (Pseudogene)
TNXB Tenascin XB
TUBA1A Tubulin Alpha 1a
TUBA1B Tubulin Alpha 1b
TUBA1C Tubulin Alpha 1c
TUBA3E Tubulin Alpha 3e
TUBA4A Tubulin Alpha 4a
TUBA8 Tubulin Alpha 8
TUBB Tubulin Beta Class I
TUBB1 Tubulin Beta 1 Class VI
TUBB2A Tubulin Beta 2A Class IIa
TUBB2B Tubulin Beta 2B Class IIb
TUBB3 Tubulin Beta 3 Class III
TUBB4A Tubulin Beta 4A Class IVa
TUBB4B Tubulin Beta 4B Class IVb
TUBB6 Tubulin Beta 6 Class V
TUBB8 Tubulin Beta 8 Class VIII
TUBB8B Tubulin Beta 8B

Regarding the proteins in common in both synovial fluid and disc in the same sample groups, DDWoR presented two common proteins, MD presented three proteins, group CH had no protein in common, and the three groups together had six proteins in common (Table 4).

Table 4.

Proteins expressed in both synovial fluid and TMJ disc samples of each group.

Protein Expressed in Each Group of TMJ Synovial Fluid and Disc Samples (n = 11)
DDWoR (n= 2) MD (n = 3) CH (n = 0) DDWoR and MD (n = 0) DDWoR and CH (n = 0) MD and CH (n = 0) DDWoR, MD and CH (n = 6)
CHD8 FLNA ENO1
MYL6B PPFIA1 ENO2
PPFIA2 ENO3
MYH16
RPL7L1
SHLD3

All synovial fluid and disc samples presented proteins involved in DNA repair, muscle and neural regeneration.

A selective pool of proteins was chosen to be studied according to the pathology group and protein function for synovial fluid and disc sample (Table 5 and Table 6).

Table 5.

Gene code, protein name and function for each sample of TMJ synovial fluid.

Synovial Fluid Sample
Code Name Function
DDWoR
A2M Alpha-2-Macroglobulin Inhibits inflammatory cytokines.
APCS Amyloid P Component, Serum Binds to apoptotic cells at an early stage.
GPSM2 G Protein Signaling Modulator 2 Involved in the development of normal hearing.
KRT18 Keratin 18 Is involved in interleukin-6-mediated barrier protection.
MAP3K7 Mitogen-Activated Protein Kinase Kinase Kinase 7 Mediates signal transduction various cytokines including interleukin-1, transforming growth factor-beta, bone morphogenetic protein 2 and 4, Toll-like receptors, tumor necrosis factor receptor CD40 and B-cell receptor.
SERPINC1 Serpin Family C Member 1 This protein inhibits thrombin and it regulates the blood coagulation cascade.
MD
ALDH1L1 Aldehyde Dehydrogenase 1 Family Member L1 Associated with decreased apoptosis, increased cell motility, and cancer progression.
C4A Complement C4A (Rodgers Blood Group) An antimicrobial peptide and a mediator of local inflammation.
HPX Hemopexin Acute phase protein that transports heme from the plasma to the liver and may be involved in protecting cells from oxidative stress.
IFT122 Intraflagellar Transport 122 Involved in cell cycle progression, signal transduction, apoptosis, and gene regulation.
MYO6 Myosin VI This protein maintains the structural integrity of inner ear hair cells and mutations in this gene cause hearing loss.
PRDX1 Peroxiredoxin 1 Has an antioxidant protective role in cells and may contribute to the antiviral activity of CD8(+) T-cells.
SERPINH1 Serpin Family H Member 1 Plays a role in collagen biosynthesis as a collagen-specific molecular chaperone.
SMPD3 Sphingomyelin Phosphodiesterase 3 Mediates cellular functions, such as apoptosis and growth arrest.
CH
ADH1 Alcohol Dehydrogenase Subunit Alpha Catalyzes the oxidation of alcohols to aldehydes.
DDWoR and MD
ANXA1 Annexin A1 Inhibits phospholipase A2 and has anti-inflammatory activity.
ANXA2 Annexin A2 Functions as an autocrine factor which heightens osteoclast formation and bone resorption.
ASPN Asporin Regulate chondrogenesis by inhibiting transforming growth factor-beta 1-induced gene expression in cartilage. May induce collagen mineralization.
BGN Biglycan Plays a role in bone growth, muscle development and regeneration, and collagen fibril assembly in multiple tissues. This protein may also regulate inflammation and innate immunity.
CILP Cartilage Intermediate Layer Protein This protein is present in the cartilage intermediate layer protein (CILP), which increases in early osteoarthrosis cartilage.
CLU Clusterin Under stress conditions can be found in the cell cytosol. May be involved in cell death, tumor progression, and neurodegenerative disorders
COMP Thrombospondin-5 Present in rheumatoid arthritis, is a noncollagenous extracellular matrix protein.
DCN Decorin Has a stimulatory effect on autophagy and inflammation and an inhibitory effect on angiogenesis and tumorigenesis.
FMOD Fibromodulin May also regulate TGF-beta activities by sequestering TGF-beta into the extracellular matrix.
FN1 Fibronectin 1 Fibronectin is involved in cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense.
IGHG1 Immunoglobulin Heavy Constant Gamma 1 (G1m Marker) Involved in pathways of Interleukin-4 and 13 signaling and IL4-mediated signaling events.
DDWoR and CH
x x x
MD and CH
x x x
DDWoR, MD and CH
ENO2 Enolase 2 Found in mature neurons and cells of neuronal origin.
ENO3 Enolase 3 May play a role in muscle development and regeneration.

Table 6.

Gene code, protein name and function for each sample of TMJ discs.

Disc Sample
Code Name Function
DDWoR
AMBP Alpha-1-Microglobulin/Bikunin Precursor Regulation of the inflammatory process.
MMP10 Matrix Metallopeptidase 10 Breakdown of extracellular matrix.
MMP27 Matrix Metallopeptidase 27 Breakdown of extracellular matrix.
MMP3 Matrix Metallopeptidase 3 Breakdown of extracellular matrix.
PLA2G7 Phospholipase A2 Group VII Inflammatory and oxidative stress response.
THADA THADA Armadillo Repeat Containing Apoptosis pathway.
THBS3 Thrombospondin 3 Matrix interactions.
MD
AKAP13 A-kinase anchor protein 13 Regulation of apoptotic process.
CCDC88A Girdin Vascular endothelial growth factor receptor 2 binding.
COL4A1 Collagen alpha-1(IV) chain Extracellular matrix structural constituent.
ERAS GTPase ERas Tumor-like growth properties of embryonic stem cells.
ERBIN Erbin Inhibits NOD2-dependent NF-kappa-B signaling and proinflammatory cytokine secretion.
PARP10 Protein mono-ADP-ribosyltransferase PARP10 Negative regulation of fibroblast proliferation.
PPFIA1 Liprin-alpha-1 Cell–matrix adhesion.
PPFIA2 Liprin-alpha-2 Cell–matrix adhesion.
PTPN7 Tyrosine-protein phosphatase non-receptor type 7 Regulation of T and B-lymphocyte development and signal transduction.
UPK3A Uroplakin-3a Epithelial cell differentiation.
CH
ACTN4 Actinin Alpha 4 Transcriptional coactivator.
ADAM10 ADAM Metallopeptidase Domain 10 Responsible for the FasL ectodomain shedding.
COQ8B Coenzyme Q8B Biosynthesis of coenzyme Q.
HPX Hemopexin Protect cells from oxidative stress.
HSPA1A Heat Shock Protein Family A (Hsp70) Member 1A Protection of the proteome from stress.
NEK10 NIMA Related Kinase 10 Cellular response to UV irradiation.
PDLIM4 PDZ And LIM Domain 4 Involved in bone development.
SERPINH1 Serpin Family H Member 1 Chaperone in the biosynthetic pathway of collagen.
TTR Transthyretin Thyroid hormone-binding protein.
COL1A2 Collagen Type I Alpha 2 Chain Fibril-forming collagen abundant in bone.
PRG4 Proteoglycan 4 This protein contains both chondroitin sulfate and keratan sulfate glycosaminoglycans.
PTPN13 Protein Tyrosine Phosphatase Non-Receptor Type 13 Regulates negatively FasL induced apoptosis.
DDWoR and MD
C4A Complement C4A Antimicrobial peptide and a mediator of local inflammation.
C4B Complement C4B Mediator of local inflammation.
C4B_2 Complement Component 4B Mediator of local inflammatory process.
SEMA4F Semaphorin 4F Plays a role in neural development.
Code Name Function
DDWoR and CH
ACAN Aggrecan Part of the extracellular matrix that withstands compression in cartilage.
COL1A1 Collagen Type I Alpha 1 Chain Collagen component.
COL4A6 Collagen Type IV Alpha 6 Chain Major structural component of basement membranes.
HSPA2 Heat Shock Protein Family A (Hsp70) Member 2 Protection of the proteome from stress.
POSTN Periostin Extracellular matrix protein that functions in tissue development and regeneration, including wound healing.
MD and CH
KRT6A Keratin 6A Epidermis-specific type I keratin involved in wound healing.
DDWoR, MD and CH
ANXA1 Annexin A1 Anti-inflammatory activity.
ANXA2 Annexin A2 Heightens osteoclast formation and bone resorption.
ANXA2P2 Annexin A2 Pseudogene 2 May be involved in heat-stress response.
APCS Amyloid P Component Is involved in dealing with apoptotic cells in vivo.
ASPN Asporin Regulates chondrogenesis by inhibiting transforming growth factor-beta 1-induced gene expression in cartilage
BGN Biglycan Plays a role in bone growth, and collagen fibril assembly in multiple tissues. This protein may also regulate inflammation and innate immunity.
C3 Complement C3 Modulates inflammation and possesses antimicrobial activity.
CILP Cartilage Intermediate Layer Protein Increases in early osteoarthrosis cartilage.
COL12A1 Collagen Type XII Alpha 1 Chain Type XII collagen.
COL14A1 Collagen Type XIV Alpha 1 Chain Type XIV collagen.
COL6A1 Collagen Type VI Alpha 1 Chain Collagen VI.
COL6A2 Collagen Type VI Alpha 2 Chain Type VI collagen.
COL6A3 Collagen Type VI Alpha 3 Chain Ttype VI collagen.
COMP Cartilage Oligomeric Matrix Protein Degradation of the extracellular matrix.
ENO1 Enolase 1 Tumor suppressor.
ENO2 Enolase 2 Found in mature neurons and cells of neuronal origin.
ENO3 Enolase 3 Plays a role in muscle development and regeneration.
FN1 Fibronectin 1 Involved in wound healing, blood coagulation, host defense.
KRT7 Keratin 7 Co-expressed during differentiation of simple and stratified epithelial tissues.
LUM Lumican May regulate collagen fibril organization, epithelial cell migration and tissue repair.
MFAP4 Microfibril Associated Protein 4 Extracellular matrix protein which is involved in cell adhesion or intercellular interactions.
MFGE8 Milk Fat Globule EGF And Factor V/VIII Domain Containing Promotes phagocytosis of apoptotic cells. This protein has also been implicated in wound healing, autoimmune disease, and cancer.
OGN Osteoglycin Induces ectopic bone formation in conjunction with transforming growth factor beta and may regulate osteoblast differentiation.
SOD3 Superoxide Dismutase 3 Antioxidant enzymes that protect tissues from oxidative stress.
TGFBI Transforming Growth Factor Beta Induced May be involved in endochondrial bone formation in cartilage.
TNC Tenascin C Modulation of inflammatory cytokine.
TNXB Tenascin XB Accelerates collagen fibril formation.
VCAN Versican A large chondroitin sulfate proteoglycan and is a major component of the extracellular matrix.
VIM Vimentin Involved in the stabilization of type I collagen mRNAs for CO1A1 and CO1A2.

The synovial fluid sample presented the following proteins functions for each group (Table 5): the DDWoR group presented proteins involved in inflammatory process, apoptosis, hearing, interleukine-6 cascade, and protection against oxidative stress; the MD group showed proteins involved in inflammatory process, apoptosis, hearing, interleukine-6 cascade, protection against oxidative stress, and immune response; in the CH group, the expression of alcohol degradation protein (ADH1) was identified. The group comprising the pathologies DDWoR and MD were mainly involved in inflammatory process inhibition, bone resorption, chondrogenesis, bone and cartilage formation, osteoarthrosis, and neuropathic pain. No proteins were observed in the groups DDWoR and CH, and MD and CH. The proteins expressed in all three groups (DDWoR, MD and CH) were mainly implicated with muscle regeneration.

The disc sample presented the following protein functions for each group (Table 6): the DDWoR group expressed proteins involved in inflammatory process, neurogenesis, cartilage formation, extracellular matrix degradation, oxidative stress and apoptosis. The MD group presented proteins related to apoptosis, vascular growth, inflammatory inhibitors, immunologic factors and epithelial growth, and the CH group showed protein expression implicated in apoptosis, apoptosis inhibition, oxidative stress, bone formation, chondroitin, bone and cartilage formation. The group with DDWoR and MD samples had proteins involved in inflammatory process; the group with DDWoR and CH samples showed proteins with collagen formation and wound healing functions; the group with MD and CH was involved in wound healing; and the group containing DDWoR, MD and CH samples was involved with inflammatory cascade modulation, osteoclastogenesis, chondrogenesis, apoptosis, bone formation, vascular and tissue repair, antioxidative activity.

There were proteins identified in both synovial fluid and TMJ disc samples, however, some of them in different pathology groups (Table 7).

Table 7.

Name and function of expressed proteins in common between synovial fluid and TMJ disc sample, and the groups in each protein was expressed.

Name Function Disc Synovial Fluid
Amyloid P Component, Serum Is involved in dealing with apoptotic cells in vivo. DDWoR, MD and CH DDWoR
Annexin A1 Anti-inflammatory activity. DDWoR, MD and CH DDWoR and MD
Annexin A2 Heightens osteoclast formation and bone resorption. DDWoR, MD and CH DDWoR and MD
Asporin Regulates chondrogenesis. DDWoR, MD and CH DDWoR and MD
Biglycan Plays a role in bone growth, and collagen fibril assembly in multiple tissues. DDWoR, MD and CH DDWoR and MD
Cartilage Intermediate Layer Protein Increases in early osteoarthrosis cartilage. DDWoR, MD and CH DDWoR and MD
Complement C4A Antimicrobial peptide and a mediator of local inflammation. DDWoR and MD MD
Enolase 2 Found in mature neurons and cells of neuronal origin. DDWoR, MD and CH DDWoR, MD and CH
Enolase 3 Play a role in muscle development and regeneration. DDWoR, MD and CH DDWoR, MD and CH
Fibronectin 1 Involved in wound healing, blood coagulation, host defense. DDWoR, MD and CH DDWoR and MD
Hemopexin Protect cells from oxidative stress. CH MD
Lumican May regulate collagen fibril organization, epithelial cell migration and tissue repair. DDWoR, MD and CH DDWoR and MD
Osteoglycin Regulate osteoblast differentiation. DDWoR, MD and CH DDWoR and MD
Serpin Family H Member 1 Chaperones in the biosynthetic pathway of collagen. CH MD
Superoxide Dismutase 3 Antioxidant enzymes that protect tissues from oxidative stress. DDWoR, MD and CH DDWoR and MD
Tenascin XB Modulation of inflammatory cytokine. DDWoR, MD and CH DDWoR and MD
Transforming Growth Factor Beta Induced May be involved in endochondral bone formation in cartilage. DDWoR, MD and CH DDWoR and MD
Versican A large chondroitin sulfate proteoglycan and is a major component of the extracellular matrix. DDWoR, MD and CH DDWoR and MD

Different types of collagen were identified in discs of the MD group, CH group, DDWoR and CH group, and in the group with all pathologies together (DDWoR, MD and CH). Besides the known collagen type I present in TMJ discs, collagen type IV, VI, XII and XIV were also identified (Table 8).

Table 8.

Types of collagen identified in each TMJ disc group.

Type of Collagen Identified in Each Group
DDWoR MD CH DDWoR and MD DDWoR and CH MD and CH DDWoR, MD and CH
x Code Name Code Name x Code Name x Code Name
COL4A1 Collagen Type IV Alpha 1 Chain COL1A2 Collagen Type I Alpha 2 Chain COL1A1 Collagen Type I Alpha 1 Chain COL12A1 Collagen Type XII Alpha 1 Chain
COL4A6 Collagen Type IV Alpha 6 Chain COL14A1 Collagen Type XIV Alpha 1 Chain
COL6A1 Collagen Type VI Alpha 1 Chain
COL6A2 Collagen Type VI Alpha 2 Chain
COL6A3 Collagen Type VI Alpha 3 Chain

All shared and group-specific proteins are indicated in a Venn diagram for the synovial fluid (Figure 1) and disc samples (Figure 2).

Figure 1.

Figure 1

Venn diagram for synovial fluid: group 1—DDWoR, group 2—MD, group 3—CH.

Figure 2.

Figure 2

Venn diagram for the TMJ disc: group 1—DDWoR, group 2—MD, group 3—CH.

The interactions between the proteins were analyzed with Genemania (https://genemania.org—accessed on 5 September 2020), and its genetic network pointed out distinct protein cascades that might be modulating each pathology through the synovial fluid and disc samples. The physical and genetic interactions, co-expression and pathway of the proteins are shown in Figure 3 and Figure 4.

Figure 3.

Figure 3

Figure 3

Gene interactions between the main functional proteins of synovial fluid. (A) showing the gene interactions of the DDWoR group. (B) showing the gene interactions of the MD group. (C) showing the gene interactions of the CH group. (D) showing the gene interactions of the DDWoR and MD group. (E) showing the gene interactions of the DDWoR, MD and CH group.

Figure 4.

Figure 4

Figure 4

Figure 4

Gene interactions between the main functional proteins of the TMJ disc. (A) showing the gene interactions of the DDWoR group. (B) showing the gene interactions of the MD group. (C) showing the gene interactions of the CH group. (D) showing the gene interactions of the CH group. (E) showing the gene interactions of the DDWoR and CH group. (F) showing the gene interactions of the MD and CH group. (G) showing the gene interactions of the DDWoR, MD and CH group.

The main proteins with important functions and networks that were identified in the synovial fluid sample were analyzed for each group (Figure 3). A brief description of these findings are: in the DDWoR group (Figure 3A) alpha-2-macroglobulin (A2M) involved in inflammatory process, amyloid P component (APCS) involved with apoptosis and complement factor H (CFH) that modulates inflammatory cascade were highlighted in the Genemania interaction figure; in the MD group (Figure 3B), hemopexin (HPX) involved in protection against oxidative stress was present; in the CH group (Figure 3C), alcohol dehydrogenase subunit alpha (ADH1) that is responsible for alcohol degradation and interacts with growth hormone receptor (GHR) was present. In the group of DDWoR and MD (Figure 3D), annexin A1 (ANXA1), decorin (DCN), and immunoglobulin heavy constant gamma 1 (IGHG1) involved in inflammatory process, annexin A2 (ANXA2) involved with bone resorption, asporin (ASPN), biglycan (BGN), cartilage intermediate layer protein (CILP), osteoglycin (OGN), transforming growth factor beta induced (TGFBI) involved in bone and cartilage formation, fibronectin 1 (FN1), lumican (LUM) and tenascin XB (TNXB) involved in tissue repair, and neurofilament medium (NEFM) and thrombospondin 4 (THBS4) involved in neuropathic pain were included in the net. The DDWoR and CH group, and MD and CH group had no protein to be analyzed. The group with the three pathologies (DDWoR, MD and CH) showed an interaction of enolase 2 (ENO2) and 3 (ENO3), involved in muscle regeneration (Figure 3E).

The disc sample presented the following protein interactions in Genemania (Figure 4): group DDWoR (Figure 4A) presented mainly the matrix metalloproteinase protein (MMP) family (1,2,3,6,8,10,13,15,16), integrin subunit alpha 6 (ITGA6) and phospholipase A2 group VII (PLA2G7) that are involved in inflammatory cascade. Additionally, thrombospondin 3 (THBS3) and 4 (THBS4) involved in tissue remodeling, and THADA armadillo repeat containing (THADA) involved in apoptosis were present. In the MD group (Figure 4B), A-kinase anchor protein 13 (AKAP13), Erbin (ERBIN) and uroplakin-3a (UPK3A) involved in apoptosis, collagen alpha-1(IV) chain (COL4A1) and GTPase Eras (ERAS) involved in disc matrix constitution, and liprin-alpha-1 (PPFIA1) and (PPFIA2) 2 responsible for cell interactions were identified in the Genemania network. In the CH group (Figure 4C), the present proteins were ADAM metallopeptidase domain 10 (ADAM10), that regulates apoptosis, collagen type I alpha 2 chain (COL1A2) and serpin family H member 1 (SERPINH1) involved in collagen formation, actinin alpha 4 (ACTN4), PDZ Additionally, LIM domain 4 (PDLIM4), transthyretin (TTR) and protein tyrosine phosphatase non-receptor type 13 (PTPN13) involved in apoptosis, hormone modulation and bone formation. In the group of DDWoR and MD (Figure 4D), the complement C4A (C4A) and complement C4B (C4B) proteins that mediates the inflammatory process were identified. In the DDWoR and CH group (Figure 4E), mainly the proteins aggrecan (ACAN), collagen type I alpha 1 chain (COL1A1) and collagen type IV alpha 6 chain (COL4A6) that constitutes disc matrix, and periostin (POSTN) involved in wound healing were identified. In the MD and CH group (Figure 4F), keratin 6A (KRT6A) involved in wound healing was identified. Additionally, in the group with all three pathologies (DDWoR, MD and CH) the proteins that interacted were annexin A1 (ANXA1), complement C3 (C3) and tenascin C (TNC) involved in inflammatory cascade modulation, annexin A2 (ANXA2) and transforming growth factor beta induced (TGFBI) involved in osteoclastogenesis, asporin (ASPN), biglycan (BGN), collagen type VI alpha 1 chain (COL6A1), osteoglycin (OGN) and vimentin (VIM) involved in chondrogenesis and osteogenesis, amyloid P component (APCS) and complement C3 (C3) in apoptosis and lumican (LUM) involved in tissue repair (Figure 4G).

4. Discussion

The different types of TMD may jeopardize patients’ quality of life, masticatory function and have a great impact on health expenses. The identification of its multifactorial etiological components will enhance the employment of specific treatments, diminishing the hazard it causes in the TMJ. Therefore, the identification of the proteins expressed on each pathology group of this study (DDWoR, MD, and CH) might elucidate the cascades involved in the progression and severity of each TMD, leading to an assertive handling of TMD.

A total of 225 proteins were identified in the synovial fluid sample, and 379 in the TMJ disc sample (Table 2). It is important to highlight that the synovial fluid sample is very complex to obtain, therefore some proteins might not have been identified due to the technique that advocates the dilution of the synovial fluid. Nevertheless, the sample was collected according to worldwide employed standard methods previously described by other research groups [21,25]. Additionally, even though few proteins’ expression might not have been observed, the expression of new proteins were identified for each pathology group, which enriches the global analysis of this study.

In our analysis, we found that all proteins expressed in the DDWoR group (synovial fluid and disc sample) (Table 2 and Table 3) presented many proteins related to inflammatory process (MMP-3, -10, -27 in the disc sample) and apoptosis (mitogen-activated protein kinase 7—MAP3K7) and THADA in synovial fluid). Only the MMP-3 protein was previously associated with TMD [26,27]. These are proteins that highly impact the degeneration process in the TMJ of patients with DDWoR [26,28]. In the MD group, ERBIN protein was found in the disc sample, and it modulates TGFB, which was previously associated with TMJ degeneration [29]. Additionally, unprecedented proteins were seen in the synovial fluid associated with apoptosis (aldehyde dehydrogenase 1 family member L—ALDH1L1) and protection against oxidative stress (HPX), which probably helps diminish the mechanical overload consequences of the dislocation in the TMJ. Regarding CH proteins in the synovial fluid sample, ADH1 catalyzes the oxidation of alcohols to aldehydes, but as seen in Genemania (Figure 3C), it interacts with GHR, which might be involved with the condylar overgrowth. In a previous study, GHR has been injected in rabbits’ TMJ to increase cartilage thickness [30], but it has not been studied as a possible etiology of condylar overgrowth yet.

Additionally, we also found a set of proteins to be common in both synovial fluid and disc samples (Table 4) in the groups DDWoR (chromodomain-helicase-DNA-binding protein 8 and myosin light chain 6B), MD (filamin A and liprin-alpha-1), and in the three groups (enolase 1, 2, 3, myosin heavy chain 16, ribosomal protein L7 like 1 and component of the shield in complex). These proteins were involved in cell matrix adhesion, cellular motor protein, reorganization of cytoskeleton, muscle development and regeneration. Additionally, another group of proteins were identified in both synovial fluid and disc samples (Table 7), being prevalent in all groups of disc samples. In the DDWoR and MD groups of synovial fluid samples, proteins implicated in apoptosis, inflammatory process, bone formation and resorption, chondrogenesis, wound healing, tissue repair and protection against oxidative stress were found. CH disc samples and MD synovial fluid samples presented, as common proteins, HPX (protection against oxidative stress) and SERPINC1 (biosynthetic pathway of collagen).

LUM is associated with the regulation of collagen fibers and with cell migration. In this study, LUM was present in all disc samples, and it has been pointed out to be elevated when the disc is under stress, as it enhances tissue repair [31]. Ulmner [32] reported that higher levels of LUM in synovial tissue might diminish TMD surgical success. On the other hand, TNC was present in all disc samples and in DDWoR and MD synovial fluid sample, being an important protein in wound healing [33].

Temporomandibular joint discs are fibrocartilaginous discs composed mainly by collagen, glycosaminoglycan and proteoglycans [34]. Studies in human adults and fetuses showed the expression of mainly collagen type I and III in TMJ discs, with type I collagen observed in the posterior band of the articular disc and collagen type III on the inferior surface of the articular disc [35,36]. Moreover, collagen type II synthesis was expressed on the external layer of the TMJ disc [37]. In this study, collagen type IV was identified in MD and CH samples (Table 8), and a previous study observed the presence of collagen type IV in the middle part of fetuses’ TMJ disc, indicating the development of blood vessels [38]. The TMJ disc is an avascular tissue, although under stress it may undergo metaplasia, forming a vascularized fibrous tissue. Collagen type VII was present in all samples, and along with collagen type IV, it has chondroprotective effects against inflammation [39]. Collagen type XII and XIV were present in the disc samples of this study, which have never been identified in this region before in humans. A study identified collagen type XII only in bovine disc samples, which helps maintain collagen type I integrity [40]. Nevertheless, collagen type XIV was also observed in all TMJ disc samples, and it plays an essential structural role in the integrity of collagen type I, mechanical properties, organization, and shape of articular cartilage, which has never been described in the TMJ disc before [41]. This is important information to understand the composition’s strength and weakness of the TMJ disc.

5. Conclusions

In conclusion, many proteins were identified for the first time in the TMJ disc and synovial fluid of the groups DDWoR, MD and CH, leading to the enlightenment of each pathology’s etiology, modulation and progression. Further studies with a greater sample are necessary to evaluate other proteins that might be present in these pathologies as well.

Acknowledgments

We thank all individuals that were volunteers for agreeing to participate in this study. A.D.D. was supported by Fundação Araucária scholarship. P.C.T. is supported by the National Council for Scientific and Technological Development, Chamada MCTIC/CNPq Nº 28/2018—Universal, Process: 426505/2018-2 for this research. R.H.H. is supported by Fundação Araucária (grant FA#09/2016). We thank Alexandra Senegaglia and Paulo R. S. Brofman for the laboratory support at Pontifícia Universidade Católica do Paraná, Brazil.

Author Contributions

Conceptualization: A.D.D., P.C.T., R.H.H.; methodology: A.D.D., P.C.T., R.H.H., M.A.R.B.; software: A.D.D., R.H.H., M.A.R.B.; validation: A.D.D., P.C.T., R.H.H., M.A.R.B.; formal Analysis: A.D.D., P.C.T., R.H.H., M.A.R.B.; investigation: A.D.D., P.C.T., R.H.H., M.A.R.B.; resources: A.D.D., P.C.T., R.H.H.; data curation: A.D.D., P.C.T., R.H.H., M.A.R.B.; writing—original draft preparation A.D.D., R.H.H.; writing—review and editing: A.D.D., P.C.T., R.H.H., M.A.R.B.; supervision: P.C.T., R.H.H., M.A.R.B.; project administration: A.D.D.; funding acquisition: A.D.D., P.C.T., R.H.H. All authors have read and agreed to the published version of the manuscript.

Funding

P.C.T. is supported by the National Council for Scientific and Technological Development, Chamada MCTIC/CNPq Nº 28/2018—Universal, Process: 426505/2018-2 for this research. R.H.H. is supported by Fundação Araucária (grant FA#09/2016).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of Pontifical Catholic University of Paraná, Brazil, according to Resolution 196/96 of the National Health Council and approved under registration number 1.863.521, on the 20 May 2016.

Informed Consent Statement

Written informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data is contained within the article.

Conflicts of Interest

The authors declare no conflict of interest.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Slade G.D., Ohrbach R., Greenspan J.D., Fillingim R.B., Bair E., Sanders A.E., Dubner R., Diatchenko L., Meloto C.B., Smith S., et al. Painful Temporomandibular Disorder: Decade of Discovery from OPPERA Studies. J. Dent. Res. 2016;95:1084–1092. doi: 10.1177/0022034516653743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.National Institute of Health. [(accessed on 3 October 2019)]; Available online: https://www.nidcr.nih.gov/health-info/tmj.
  • 3.Ohrbach R., Dworkin S.F. The Evolution of TMD Diagnosis: Past, Present, Future. J. Dent. Res. 2016;95:1093–1101. doi: 10.1177/0022034516653922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Minervini G., Lucchese A., Perillo L., Serpico R., Minervini G. Unilateral superior condylar neck fracture with disloca-tion in a child treated with an acrylic splint in the upper arch for functional repositioning of the mandible. Case Rep. Cranio. 2017;35:337–341. doi: 10.1080/08869634.2016.1203560. [DOI] [PubMed] [Google Scholar]
  • 5.Eberhard D., Bantleon H., Steger W. The efficacy of anterior repositioning splint therapy studied by magnetic resonance imaging. Eur. J. Orthod. 2002;24:343–352. doi: 10.1093/ejo/24.4.343. [DOI] [PubMed] [Google Scholar]
  • 6.Supplement D., Minervini G., Nucci L., Lanza A., Femiano F., Contaldo M., Grassia V. Temporomandibular disc displacement with reduction treated with anterior repositioning splint: A 2-year clinical and magnetic resonance imaging (MRI) follow-up. Case Rep. J. Biol. Regul. Homeost. Agents. 2020;34:151–160. [PubMed] [Google Scholar]
  • 7.Talaat W.M., Adel O.I., Al Bayatti S. Prevalence of temporomandibular disorders discovered incidentally during routine dental examination using the Research Diagnostic Criteria for Temporomandibular Disorders. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2018;125:250–259. doi: 10.1016/j.oooo.2017.11.012. [DOI] [PubMed] [Google Scholar]
  • 8.Cakarer S., Isler S., Yalcin B., Şitilci T. Management of the bilateral chronic temporomandibular joint dislocation. Ann. Maxillofac. Surg. 2018;8:154. doi: 10.4103/ams.ams_142_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Poluha R.L., Canales G.D.L.T., Costa Y.M., Grossmann E., Bonjardim L.R., Conti P.C.R. Temporomandibular joint disc displacement with reduction: A review of mechanisms and clinical presentation. J. Appl. Oral Sci. 2019;27:e20180433. doi: 10.1590/1678-7757-2018-0433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Fayed M.M.S., El-Mangoury N.H., El-Bokle D.N., Belal I.A. Occlusal splint therapy and magnetic resonance imaging. World J. Orthod. 2004;5:133–140. [PubMed] [Google Scholar]
  • 11.Prechel U., Ottl P., Ahlers O.M., Neff A. The Treatment of Temporomandibular Joint Dislocation: A Systematic Review. Dtsch. Arztebl. Int. 2018;115:59–64. doi: 10.3238/arztebl.2018.0059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Nitzan D.W., Katsnelson A., Bermanis I., Brin I., Casap N. The clinical characteristics of condylar hyperplasia: Expe-rience with 61 patients. J. Oral Maxillofac. Surg. 2008;66:312–318. doi: 10.1016/j.joms.2007.08.046. [DOI] [PubMed] [Google Scholar]
  • 13.Raijmakers P.G., Karssemakers L.H., Tuinzing D.B. Female Predominance and Effect of Gender on Unilateral Condylar Hyperplasia: A Review and Meta-Analysis. J. Oral Maxillofac. Surg. 2012;70:72–76. doi: 10.1016/j.joms.2011.05.026. [DOI] [PubMed] [Google Scholar]
  • 14.Mahajan M. Unilateral condylar hyperplasia—A genetic link? Case reports. Nat. J. Maxillofacial Surg. 2017;8:58–63. doi: 10.4103/njms.NJMS_64_16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Herr M.M., Fries K.M., Upton L.G., Edsberg L.E. Potential Biomarkers of Temporomandibular Joint Disorders. J. Oral Maxillofac. Surg. 2011;69:41–47. doi: 10.1016/j.joms.2010.05.013. [DOI] [PubMed] [Google Scholar]
  • 16.Demerjian G.G., Sims A.B., Stack B.C. Proteomic signature of Temporomandibular Joint Disorders (TMD): Toward di-agnostically predictive biomarkers. Bioinformation. 2011;6:282–284. doi: 10.6026/97320630005282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.DuPree E.J., Jayathirtha M., Yorkey H., Mihasan M., Petre B.A., Darie C.C. A Critical Review of Bottom-Up Proteomics: The Good, the Bad, and the Future of this Field. Proteomes. 2020;8:14. doi: 10.3390/proteomes8030014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Murphy M.K., MacBarb R.F., Wong M.E., Athanasiou K.A. Temporomandibular Joint Disorders: A Review of Etiology, Clinical Management, and Tissue Engineering Strategies. Int. J. Oral Maxillofac. Implant. 2013;28:393–414. doi: 10.11607/jomi.te20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Olate S., Netto H.D., Rodriguez-Chessa J., Alister J.P., Albergaria-Barbosa J.P., de Moraes J. Mandible condylar hy-perplasia: A review of diagnosis and treatment protocol. Int J. Clin. Exp. Med. 2013;6:727–737. [PMC free article] [PubMed] [Google Scholar]
  • 20.Mehra P., Wolford L.M. Serum nutrient deficiencies in the patient with complex temporomandibular joint problems. Bayl. Univ. Med. Cent. Proc. 2008;21:243–247. doi: 10.1080/08998280.2008.11928403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Alstergren P., Benavente C., Kopp S. Interleukin-1beta, interleukin-1 receptor antagonist, and interleukin-1 soluble receptor II in temporomandibular joint synovial fluid from patients with chronic polyarthritides. J. Oral Maxillofac. Surg. 2003;61:1171–1178. doi: 10.1016/S0278-2391(03)00678-5. [DOI] [PubMed] [Google Scholar]
  • 22.Cassiano L.P., Ventura T.M., Silva C.M., Leite A.L., Magalhães A.C., Pessan J.P., Buzalaf M.A.R. Protein Profile of the Acquired Enamel Pellicle after Rinsing with Whole Milk, Fat-Free Milk, and Water: An in vivo Study. Caries Res. 2018;52:288–296. doi: 10.1159/000485390. [DOI] [PubMed] [Google Scholar]
  • 23.Universal Protein Resource. [(accessed on 5 September 2020)]; Available online: http://www.uniprot.org.
  • 24.Warde-Farley D., Donaldson S.L., Comes O., Zuberi K., Badrawi R., Chao P., Franz M., Grouios C., Kazi F., Lopes C.T., et al. The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010;38:214–220. doi: 10.1093/nar/gkq537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Fredriksson L., Alstergren P., Kopp S. Tumor Necrosis Factor-α in Temporomandibular Joint Synovial Fluid Predicts Treatment Effects on Pain by Intra-Articular Glucocorticoid Treatment. Mediat. Inflamm. 2006;2006:59425. doi: 10.1155/MI/2006/59425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Fujita H., Morisugi T., Tanaka Y., Kawakami T., Kirita T., Yoshimura Y. MMP-3 activation is a hallmark indicating an early change in TMJ disorders, and is related to nitration. Int. J. Oral Maxillofac. Surg. 2009;38:70–78. doi: 10.1016/j.ijom.2008.11.003. [DOI] [PubMed] [Google Scholar]
  • 27.Tiilikainen P., Pirttiniemi P., Kainulainen T., Pernu H., Raustia A. MMP-3 and -8 expression is found in the condylar surface of temporomandibular joints with internal derangement. J. Oral Pathol. Med. 2005;34:39–45. doi: 10.1111/j.1600-0714.2004.00262.x. [DOI] [PubMed] [Google Scholar]
  • 28.Loreto C., Filetti V., Almeida L.E., Rosa G.R., Leonardi R., Grippaudo C., Giudice A. MMP-7 and MMP-9 are over-expressed in the synovial tissue from severe temporomandibular joint dysfunction. Eur. J. Histochem. 2020;64:3113. doi: 10.4081/ejh.2020.3113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Da Costa G.F.A., Souza R.D.C., de Araújo G.M., Gurgel B.C.V., Barbosa G.A.S., Calderon P.D.S. Does TGF-beta play a role in degenerative temporomandibular joint diseases? A systematic review. Cranio. 2017;35:228–232. doi: 10.1080/08869634.2016.1193961. [DOI] [PubMed] [Google Scholar]
  • 30.Ulmner M., Sugars R., Naimi-Akbar A., Tudzarovski N., Kruger-Weiner C., Lund B. Synovial Tissue Proteins and Patient-Specific Variables as Predictive Factors for Temporomandibular Joint Surgery. Diagnostics. 2020;11:46. doi: 10.3390/diagnostics11010046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Feizbakhsh M., Razavi M., Minaian M., Teimoori F., Dadgar S., Maghsoodi S. The effect of local injection of the human growth hormone on the mandibular condyle growth in rabbit. Dent. Res. J. 2014;11:436–441. [PMC free article] [PubMed] [Google Scholar]
  • 32.Koyama E., Saunders C., Salhab I., Decker R., Chen I., Um H., Pacifici M., Nah H. Lubricin is Required for the Structural Integrity and Post-natal Maintenance of TMJ. J. Dent. Res. 2014;93:663–670. doi: 10.1177/0022034514535807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Stocum D.L., Roberts W.E. Part I: Development and Physiology of the Temporomandibular Joint. Curr. Osteoporos. Rep. 2018;16:360–368. doi: 10.1007/s11914-018-0447-7. [DOI] [PubMed] [Google Scholar]
  • 34.Berkovitz B.K.B., Holland G.R., Moxham B.J. Oral Anatomy, Histology and Embryology. 4th ed. Mosby; St. Louis, MD, USA: 2009. [Google Scholar]
  • 35.Gage J., Virdi A., Triffitt J., Howlett C., Francis M. Presence of type III collagen in disc attachments of human temporomandibular joints. Arch. Oral Biol. 1990;35:283–288. doi: 10.1016/0003-9969(90)90044-B. [DOI] [PubMed] [Google Scholar]
  • 36.De Moraes L.O., Lodi F.R., Gomes T.S., Marques S.R., Oshima C.T., Lancellotti C.L., Rodríguez-Vázquez J.F., Mé-rida-Velasco J.R., Alonso L.G. Immunohistochemical expression of types I and III collagen antibodies in the tem-poromandibular joint disc of human foetuses. Eur. J. Histochem. 2011;55:24. doi: 10.4081/ejh.2011.e24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Kondoh T., Hamada Y., Iino M., Takahashi T., Kikuchi T., Fujikawa K., Seto K. Regional differences of type II collagen synthesis in the human temporomandibular joint disc: Immunolocalization study of carboxy-terminal type II procollagen peptide (chondrocalcin) Arch. Oral Biol. 2003;48:621–625. doi: 10.1016/S0003-9969(03)00067-0. [DOI] [PubMed] [Google Scholar]
  • 38.De Moraes L.O., Lodi F.R., Gomes T.S., Marques S.R., Fernandes Junior J.A., Oshima C.T., Alonso L.G. Immuno-histochemical expression of collagen type IV antibody in the articular disc of the temporomandibular joint of human fe-tuses. Ital. J. Anat. Embryol. 2008;113:91–95. [PubMed] [Google Scholar]
  • 39.Chu W.C., Zhang S., Sng T.J., Ong Y.J., Tan W.-L., Ang V.Y., Foldager C.B., Toh W.S. Distribution of pericellular matrix molecules in the temporomandibular joint and their chondroprotective effects against inflammation. Int. J. Oral Sci. 2017;9:43–52. doi: 10.1038/ijos.2016.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Deng M.H., Xu J., Cai H.X., Fang W., Long X. Effect of temporomandibular joint disc perforation on expression of type ? collagen in temporomandibular joint disc cells. Chin. J. Stomatol. 2017;52:274–277. doi: 10.3760/cma.j.issn.1002-0098.2017.05.003. [DOI] [PubMed] [Google Scholar]
  • 41.Ciavarella D., Mastrovincenzo M., Sabatucci A., Campisi G., Di Cosola M., Suriano M., Muzio L.L. Primary and secondary prevention procedures of temporo-mandibular joint disease in the evolutive age. Minerva Pediatr. 2009;61:93–97. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data is contained within the article.


Articles from Diagnostics are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES